From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Jun 25, 2003
MDL Docket No. 1290 (TFH), Misc. No. 99ms276 (TFH), Civ. No. 01-2646 (TFH), 02-1299 (TFH) (D.D.C. Jun. 25, 2003)

Opinion

MDL Docket No. 1290 (TFH), Misc. No. 99ms276 (TFH), Civ. No. 01-2646 (TFH), 02-1299 (TFH).

June 25, 2003.


ORDER


Due to the Court's calendar and, in particular, a month long criminal trial starting in July 2003, it is hereby

ORDERED that the status hearing scheduled for Wednesday, July 23, 2003 is cancelled. The next hearing in this case shall be the previously scheduled status hearing set for Tuesday, September 2, 2003 at 10:30 a.m. A Joint Proposed Agenda for that status hearing shall be filed with the Court no later than 12:00 noon on Thursday, August 28, 2003. Failure to file by that time will result in the Court postponing that status hearing.

SO ORDERED.


Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Jun 25, 2003
MDL Docket No. 1290 (TFH), Misc. No. 99ms276 (TFH), Civ. No. 01-2646 (TFH), 02-1299 (TFH) (D.D.C. Jun. 25, 2003)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION. This Order applies to…

Court:United States District Court, D. Columbia

Date published: Jun 25, 2003

Citations

MDL Docket No. 1290 (TFH), Misc. No. 99ms276 (TFH), Civ. No. 01-2646 (TFH), 02-1299 (TFH) (D.D.C. Jun. 25, 2003)